This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H7N9 Neuraminidase (NA), N-His
Product Overview
BioVenic's Recombinant Influenza A H7N9 Neuraminidase (NA), N-His is a recombinant protein expressed from HEK293 Cells. Its predicted molecular weight is 50.6 kDa. The purity is>95% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL).
Specifications
Target Information
H7N9 avian influenza virus can cause severe infections and has the potential to spark a major pandemic. Influenza viruses have two primary surface glycoproteins: hemagglutinin (HA) and neuraminidase (NA). HA is responsible for the attachment of virions to terminal sialic acids (SAs) on the cell surface and facilitates the fusion of the virus with cellular membranes. NA cleaves terminal SA residues on the host cell surfaces, aiding in the release of progeny virions from infected cells.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.